These studies, undertaken in human gastric carcinoma[6], CRC[31] breast[18] and oesophageal cancer[32], identified that SPARC was a poor prognosis marker, and was associated with more aggressive and highly metastatic tumours. The gene discussed is SPARC; the disease is carcinoma of esophagus.